Reported Earlier, Exicure And Adbiotech Partner To Evaluate Burixafor Combination Therapies In Multiple Indications Including Sickle Cell Disease And Acute Myeloid Leukemia

Benzinga Newsdesk www.benzinga.com Positive 72.2%

Neg 0% Neu 0% Pos 72.2%

Comments

No comments yet. Be the first!